Comparative Effectiveness of Denosumab versus Zoledronic Acid Among Postmenopausal Women with Osteoporosis in the US Medicare Program

被引：0
|
作者：
Curtis, Jeffrey R. [1 ]
Arora, Tarun [2 ]
Liu, Ye [3 ]
Brunetti, Vanessa C. [4 ]
Lin, Tzu-Chieh [4 ]
Spangler, Leslie [4 ]
Stad, Robert K. [4 ]
McDermott, Michele [4 ]
Bradbury, Brian D. [4 ]
Kim, Min [4 ]
机构：
[1] Univ Alabama, Div Clin Immunol & Rheumatol, Birmingham, W Midlands, England
[2] Fdn Adv Sci Technol Educ & Res, Birmingham, W Midlands, England
[3] Univ Alabama Birmingham, Birmingham, AL USA
[4] Amgen Inc, Thousand Oaks, CA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2023年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2529
引用
下载
收藏
页码：5021 / 5022
页数：2
相关论文
共 50 条
  • [41] HORIZON: Yearly infusion of zoledronic acid reduces risk of fracture in postmenopausal women with osteoporosis
    不详
    FORMULARY, 2007, 42 (08) : 488 - 489
  • [42] Treatment with zoledronic acid subsequent to odanacatib prevents bone loss in postmenopausal women with osteoporosis
    Solling, A. S. Koldkjaer
    Harslof, T.
    Langdahl, B.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 (05) : 995 - 1002
  • [43] A PROSPECTIVE STUDY TO EVALUATE THE SAFETY AND EFFICACY OF ZOLEDRONIC ACID IN THE TREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN
    Sheng, C. Jen
    Chen, W. -J.
    Chang, I. -L.
    Wong, C. -Y.
    Lee, P. -Y.
    Wu, R. -W
    Hsu, S. -K
    Liang, C. -C.
    Shen, P. -W.
    Chang, T. -K
    Lin, M. -Z
    Huang, M. -J.
    Lee, Y. -M
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 : 629 - 630
  • [44] Treatment with zoledronic acid subsequent to odanacatib prevents bone loss in postmenopausal women with osteoporosis
    A.S. Koldkjær Sølling
    T. Harsløf
    B. Langdahl
    Osteoporosis International, 2019, 30 : 995 - 1002
  • [45] Safety of denosumab versus zoledronic acid in the older adults with osteoporosis: a meta-analysis of cohort studies
    Li, Weiwei
    Ning, Zeqiong
    Yang, Zhifu
    Fan, Tingting
    Yao, Minna
    Zhang, Wei
    Wang, Mingming
    Wen, Aidong
    Wang, Jingwen
    ARCHIVES OF OSTEOPOROSIS, 2022, 17 (01)
  • [46] Safety of denosumab versus zoledronic acid in the older adults with osteoporosis: a meta-analysis of cohort studies
    Weiwei Li
    Zeqiong Ning
    Zhifu Yang
    Tingting Fan
    Minna Yao
    Wei Zhang
    Mingming Wang
    Aidong Wen
    Jingwen Wang
    Archives of Osteoporosis, 2022, 17
  • [47] Cost-Effectiveness of Sequential Teriparatide/Zoledronic Acid Compared With Zoledronic Acid Monotherapy for Postmenopausal Osteoporotic Women in China
    You, Ruxu
    Liu, Jinyu
    Ke, Lei
    Yu, Guangyi
    Zhang, Yu
    Mori, Takahiro
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [48] Comparing cost-effectiveness analyses of denosumab versus zoledronic acid for the treatment of bone metastases
    Koo, Kaitlin
    Lam, Kinsey
    Mittmann, Nicole
    Konski, Andre
    Dennis, Kristopher
    Zeng, Liang
    Lam, Henry
    Chow, Edward
    SUPPORTIVE CARE IN CANCER, 2013, 21 (06) : 1785 - 1791
  • [49] Comparing cost-effectiveness analyses of denosumab versus zoledronic acid for the treatment of bone metastases
    Kaitlin Koo
    Kinsey Lam
    Nicole Mittmann
    Andre Konski
    Kristopher Dennis
    Liang Zeng
    Henry Lam
    Edward Chow
    Supportive Care in Cancer, 2013, 21 : 1785 - 1791
  • [50] Myocardial Infarction and Stroke Risks Among Patients Who Initiated Treatment with Denosumab or Zoledronic Acid for Osteoporosis
    Spangler, Leslie
    Nielson, Carrie
    Brookhart, M. Alan
    Hernandez, Rohini K.
    Stad, Robert Kees
    Lin, Tzu-Chieh
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 8 - 8
12345